|
Detailed Information
-
November 17, 2024
8:00am - 12:00pm
Type: Short Course
Capacity: N/A
The value of medical
innovation varies by stakeholder perspective. Registration authorities focus on
clinical value for patients. Payers focus on economic value, including equity,
and reward value to incentivize optimal innovation. Sustainable value-based
pricing must also meet investor needs. We explore these perspectives, focusing
on orphan diseases and, specifically, cell and gene therapies. ...
|
|
|
|